Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...
Pavel Durov, the founder and owner of Telegram, is worth $17 billion. The messaging platform has 1 billion users and is worth $30 billion. Durov has faced legal trouble in France, where authorities ...
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback